23948sdkhjf
  • {{ window.visitor.corporateClient.name }}
    Corporate solution
    {{ window.visitor.ipAccess.corporateClient.name }}
    {{ window.visitor.corporateClient.name }}

  • Welcome to our Corporate client solution

    Here you can administrate your corporate solutions users.

  • Welcome to your subscription for Life Science Nordic

  • Welcome to our Corporate client solution

    Your IP is registered with the company mentioned above and provides access to Life Science Nordic.

  • Click here to go to sign-up
Log in or create to bookmark articles
Get access to all content on Life Science Nordic
No commitment or card information required
Try Life Science Nordic now
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement
Medtech

Ambu obtains US and EU clearances for new neurology solutions

Danish endoscopy specialists hopes to broaden its neurology portfolio with new regulatory clearences.
Advertisement

Ambu has received 510(k) clearance from FDA and a european CE marking for its newest neurology offering, the Neuroline up MRI/CT solution.

Thus, the Danish public company widens its portfolio in the neurology.

Ambu, which usually works within the endoscopy sector, has been working towards broadening its scope of offerings in other parts of the sector.

Advertisement Advertisement
BREAKING
{{ article.headline }}
0.063|